HDAC10 and hereditary clear cell renal cell carcinoma: The expression of HDAC10 is inhibited in human renal cell carcinoma (RCC) cells, suggesting that HDAC10 is an independent predictor of the prognosis of RCC, and activating HDAC10 expression may be a new therapeutic strategy for advanced RCC 26.